glutamic acid has been researched along with Neurovisceral Storage Disease with Vertical Supranuclear Ophthalmoplegia in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (80.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cawley, NX; Cougnoux, A; Fellmeth, M; Navid, F; Porter, FD; Serra-Vinardell, J; Wassif, CA; Yerger, JC | 1 |
| Ahuja, M; Baydyuk, M; Brailoiu, E; Brailoiu, GC; Eckhaus, MA; Jha, A; Kim, MS; Muallem, S; Park, S; Porter, FD; Shin, DM; Wassif, CA; Wu, LG; Zeng, M; Zerfas, PM | 1 |
| Bruno, F; Canterini, S; Caporali, P; Dragotto, J; Erickson, RP; Fiorenza, MT; Mangia, F; Palladino, G; Petrosini, L | 1 |
| Bigger, BW; Bonney, DK; Imrie, J; Jones, S; O'Meara, A; Shabani, A; Wraith, JE; Wynn, RF | 1 |
| Citro, G; Cortese, G; D'Arcangelo, G; De Chiara, G; de Stefano, MC; Frank, C; Grossi, D; Merlo, D; Rufini, S; Tancredi, V | 1 |
5 other study(ies) available for glutamic acid and Neurovisceral Storage Disease with Vertical Supranuclear Ophthalmoplegia
| Article | Year |
|---|---|
Reduction of glutamate neurotoxicity: A novel therapeutic approach for Niemann-Pick disease, type C1.
Topics: Animals; Astrocytes; Ceftriaxone; Cells, Cultured; Disease Models, Animal; Excitatory Amino Acid Transporter 1; Female; Glutamic Acid; Humans; Male; Mice; Mice, Inbred BALB C; Niemann-Pick C1 Protein; Niemann-Pick Disease, Type C; Riluzole | 2021 |
Fusion of lysosomes with secretory organelles leads to uncontrolled exocytosis in the lysosomal storage disease mucolipidosis type IV.
Topics: Animals; Cells, Cultured; Excitatory Postsynaptic Potentials; Exocytosis; Glutamic Acid; Lysosomes; Mice; Miniature Postsynaptic Potentials; Mucolipidoses; Neurons; Niemann-Pick Disease, Type C; Secretory Vesicles; Transient Receptor Potential Channels | 2016 |
Developmental delay in motor skill acquisition in Niemann-Pick C1 mice reveals abnormal cerebellar morphogenesis.
Topics: Aging; Animals; Animals, Newborn; Cerebellum; Cohort Studies; Developmental Disabilities; Disease Models, Animal; Female; gamma-Aminobutyric Acid; Glutamic Acid; Intracellular Signaling Peptides and Proteins; Male; Mice, Inbred BALB C; Mice, Transgenic; Motor Skills; Myelin Sheath; Neuroglia; Niemann-Pick C1 Protein; Niemann-Pick Disease, Type C; Postural Balance; Proteins; Severity of Illness Index; Synapses | 2016 |
Successful allogeneic bone marrow transplant for Niemann-Pick disease type C2 is likely to be associated with a severe 'graft versus substrate' effect.
Topics: Bone Marrow Transplantation; Brain; Carrier Proteins; Child Development; Drug Administration Schedule; Glutamic Acid; Glycoproteins; Graft vs Host Disease; Homozygote; Humans; Immune Reconstitution Inflammatory Syndrome; Immunosuppressive Agents; Infant; Macrophages; Magnetic Resonance Imaging; Male; Motor Skills; Mutation; Niemann-Pick Disease, Type C; Phenotype; Pneumonia; Respiratory Tract Infections; Severity of Illness Index; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome; Vesicular Transport Proteins | 2010 |
Glutamatergic neurotransmission in a mouse model of Niemann-Pick type C disease.
Topics: Animals; Cells, Cultured; Disease Models, Animal; Excitatory Amino Acid Agonists; Female; Glutamic Acid; Hippocampus; Male; Mice; Mice, Inbred BALB C; Mice, Knockout; Mice, Neurologic Mutants; Niemann-Pick Disease, Type C; Organ Culture Techniques; Receptors, Glutamate; Seizures; Synaptic Transmission | 2011 |